By Business/Source
Currency:EUR
2025/FY
Stock NameRevenueRatio
Crop Science21.68B47.57%
Pharmaceuticals17.83B39.13%
Consumer Health5.81B12.74%
All other segments303M0.66%
Enabling Functions and Consolidation-48M-0.11%
By Country/Region
Currency:EUR
2025/FY
Stock NameRevenueRatio
Europe / Middle East / Africa45.58B100.00%